Bellerophon Therapeutics Inc (NASDAQ:BLPH)

1.43
Delayed Data
As of Aug 12
 +0.04 / +2.88%
Today’s Change
0.67
Today|||52-Week Range
4.49
-53.87%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Bellerophon Therapeutics Inc have a median target of 24.50, with a high estimate of 30.00 and a low estimate of 19.00. The median estimate represents a +1,613.29% increase from the last price of 1.43.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Bellerophon Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.61
Sales
$0.00
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.54%
 
 
 
 
 
 
Growthannually -27.85%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.